Purpose The present study examined the moderating effect of cigarette smoking status on the relation between anxiety sensitivity (fear of the expected negative consequences of anxiety and bodily sensations) and hazardous alcohol consumption, sexual compulsivity, and suicidality. Method A series of multiple hierarchical regressions were used to test the proposed hypothesis among a sample of 94 persons living with HIV/AIDS in the USA (64.5 % male, M age = 48.3, SD = 7.5). Fifty-seven percent of the participants (n = 54) reported past-month smoking.
Introduction
The recent work in affective science proposes that many forms of emotional symptoms and disorders may be underpinned by a smaller set of transdiagnostic vulnerability processes [1, 2] . Within this conceptualization, transdiagnostic vulnerability factors are hypothesized to be Bcausal, varying, and maintaining factors^for emotional symptoms and disorders [3] . Factors that are intrapersonal and reflect an emotion process appear to be particularly promising for HIV/AIDS research because intrapersonal factors lend themselves well to treatment via behavioral or pharmacologic intervention. Additionally, emotional components of emotional symptoms and disorders (in contrast to somatic, behavioral, or cognitive components) may be most robustly associated with health behavior problems [4] .
One such transdiagnostic vulnerability factor is anxiety sensitivity, defined as the extent to which individuals believe that anxiety and anxiety-related sensations (e.g., racing heart) have harmful personal consequences [5, 6] . Anxiety sensitivity is a relatively stable, but malleable, factor. The global anxiety sensitivity construct encompasses lower-order fears of physical, mental, and publicly observable experiences [7] . Individuals higher in anxiety sensitivity are more likely to be frightened of harmless heart palpitations because they believe these sensations will lead to cardiac arrest or other feared outcomes, whereas individuals lower in anxiety sensitivity do not fear these same sensations because they believe them to be benign. Empirically, anxiety sensitivity is distinguishable from the tendency to experience more frequent anxiety symptoms (e.g., trait anxiety) and other negative affect propensity variables [8, 9] .
Theoretically, anxiety sensitivity may be of particular importance among the HIV+ population because of the wide array of interoceptive (e.g., aversive bodily sensations, chronic stress) and exteroceptive (e.g., stigma, discrimination) stressors associated with the disease. To date, a number of studies have examined anxiety sensitivity in relation to negative affect symptoms among persons living with HIV/AIDS. For instance, Gonzalez et al. [10] found that among 51 people with HIV/AIDS (74.5 % male, mean age = 45.53), anxiety sensitivity was related to anxiety and depression symptoms, even when controlling for negative affectivity. Another work has found anxiety sensitivity to be associated with a wide variety of aversive internal states, such as anxious arousal, bodily vigilance, and interoceptive fear [11, 12] . Additionally, a study of 164 people with HIV/AIDS demonstrated a link between anxiety sensitivity cognitive concerns and suicidal ideation, above and beyond the effects of demographic variables, CD4 T cell count, and negative affectivity [13] . Another investigation found that anxiety sensitivity was related to greater HIV symptom severity among 139 people with HIV/AIDS [14] . Together, available work provides initial empirical evidence that anxiety sensitivity is related to negative mood symptoms as well as negative internal physical states among people with HIV/AIDS.
Non-HIV work has consistently shown that the association between anxiety sensitivity and mental health and health problems is conditional upon a host of moderators, including gender [15] , environmental stress [16] , social determinants of health [17] , and ethnicity [18] . As one example, the link between anxiety sensitivity and adverse mental health symptoms is stronger in females than males [19] . However, potential moderators in anxiety sensitivity-HIV-related work have not yet been explored. Continued identification of theory-based candidate moderators of the anxiety sensitivity-mental health and health behavior relations is important within the HIV+ population because it will help clarify the mechanisms underlying this linkage and identify individuals who may benefit most for interventions that target this transdiagnostic construct. A maladaptive coping explanation purports that HIV and poorer mental health and physical health problems are related, in part, because emotionally vulnerable persons (e.g., those with higher anxiety sensitivity) engage in unhealthy behavior (e.g., smoking, risky sexual behavior) in an effort to cope with their vulnerability [20] . Following this hypothesis, people with HIV/AIDS who engage in one such maladaptive health behavior (i.e., smoking) to cope with individual differences in anxiety sensitivity may be more apt to experience more distress and then be at greater risk to utilize additional maladaptive health behaviors (e.g., risky sexual behavior, self-harm) to cope with such amplified distress.
Tobacco use is one such maladaptive health behavior. People with HIV/AIDS are significantly more apt to smoke compared to the general population. For example, Niaura and colleagues [21] reported in a critical review of the extant literature that over 70 % of HIV+ outpatients smoked on a daily basis. Smoking is commonly cited as a means to cope with aversive mood and counteract fatigue, inactivity, and stress among people with HIV/AIDS [22] . Additionally, persons with elevated anxiety sensitivity report higher rates of smoking motives compared to those with lower anxiety sensitivity [23] . Paradoxically, smoking also is related to poorer mental and physical health over time [24] . Thus, individuals with high anxiety sensitivity are more likely to use tobacco as a coping method and thereby may be increasing their risk for aversive mental health and physical health symptoms. This may, in turn, be placing themselves at a greater risk for other maladaptive health behaviors (e.g., risky sexual behavior, deliberate self-harm) to cope with such distress. Thus, smoking may be moderating the relations between anxiety sensitivity and other unhealthy behaviors. This type of perspective is consistent broadly with syndemic models of HIV [25] . Thus, anxiety sensitivity-health behavior and health outcomes may be particularly robust among smokers compared to non-smokers. This perspective is supported by a non-HIV work that has found greater levels of anxiety sensitivity and smoking status (versus non-smoking or greater smoking rate) which consistently interact to predict worse mental and physical health outcomes [9, 26] .
Together, the present study evaluated the hypothesis that tobacco use status moderated the relation between anxiety sensitivity and two notable public health problems among people with HIV/AIDS: sexual compulsivity (the extent to which persons experience sexual behavior as uncontrollable and distressing) and suicidality. Each of these health problems has been found to be common among people with HIV/AIDS [27, 28] and associated with a variety of negative consequences [27, 29] . It was hypothesized that smoking status would moderate the role of anxiety sensitivity on the dependent variables, such that anxiety sensitivity would be associated with higher rates of sexual compulsivity and suicidality among individuals who reported past-month smoking, but not among individuals who did not smoke.
Method Participants
Participants included 94 adults living with HIV/AIDS recruited from AIDS service organizations in the USA. Participants were eligible for inclusion if they were between 18 and 65 years old, were previously diagnosed with HIV/AIDS per self-report, and had the cognitive capacity to give written informed consent, as assessed by their ability to read the consent form and explain the study purpose to assessment personnel. Exclusion criteria included severe suicidality, untreated severe psychological disorders (e.g., bipolar, schizophrenia), or inability to speak English at a conversational level. The majority of participants (64.5 %) were male, and the mean age was 48.3 years (SD = 7.5). Ethnically, 54.2 % of the sample identified was Black, 29.2 % as White/Caucasian, 11.4 % as Hispanic, and 5.2 % as Bmixed/other^(e.g., Native American). Although 86.5 % reported completion of high school or further education, 77.1 % of the participants reported current unemployment and 54.2 % reported earning less than $10,000 annually. The average CD4 T cell count within the sample was 552.4 (SD = 277.5, range = 28-1300), and 53.5 % self-reported AIDS diagnosis. Past-month smoking was endorsed by 57.3 % of the sample, among whom the average number of cigarettes per day was 8.9 (SD = 6.3).
Measures
Demographic (e.g., age, location, sex) and medical (e.g., HIV/ AIDS status, time living with HIV) information was selfreported by participants.
M.I.N.I. International Neuropsychiatric Interview 6.0 (MINI [30])
The MINI is a time-efficient structured diagnostic interview used to index current psychological disorders (e.g., panic disorder, major depressive disorder) based on DSM-IV criteria [31] . The MINI was utilized to screen for study exclusion criteria and was administered by trained research personnel under the supervision of an independent doctoral-level rater. The MINI has demonstrated satisfactory inter-rater reliability, test-retest reliability, and validity and has been deemed applicable for use in research settings [32] . A random selection of interviews (approximately 12 %) was checked for accuracy with no cases of diagnostic disagreement noted.
The Timeline Follow-Back (TLFB) Interview [33] The TLFB interview is a calendar-based assessment that was originally developed to assess alcohol use but has been adapted for other substances, including tobacco [34] . Data on the quantity and frequency of cigarette use was collected using participant recall about smoking behavior in the past month, guided by clinicians trained in gathering accurate substance use information. Participants who indicated not having smoked cigarettes were coded as non-smokers (dummy code = 0), and participants indicating one or more days of cigarette use were coded as smokers (dummy code = 1). This method of data collection has been found to have strong psychometric properties for up to 90 days of retrospective recall, including excellent interrater reliability, and test-retest reliability, as well as strong convergent validity [34] .
Positive and Negative Affect Schedule (PANAS [35] ) The PANAS is a 20-item self-report measure on which respondents indicate, on a 5-point Likert-type scale (1 = very slightly or not at all; 5 = extremely), the extent to which they experience a range of different emotions (e.g., Binterested,B nervous^). In the current study, only items indexing negative affect were utilized (PANAS-NA); the subscale displayed good internal consistency (Cronbach's α = .83).
Anxiety Sensitivity Index-3 (ASI-3 [36] ) The ASI-3 is an 18-item self-report measure on which participants rate the extent to which they concerned about the possible negative consequences of anxiety (e.g., BIt scares me when my heart beats fast^) on a Likert-type scale (0 = very little; 4 = very much). The ASI-3 was adapted from the anxiety sensitivity index (ASI; [37] ) to improve psychometrics. In the present study, we utilized the ASI-3 total score (sum of scores for all 18 ASI-3 items; score ranges from 0 to 72). Internal consistency of ASI-3 was excellent (Cronbach's α = .91).
Sexual Compulsivity Scale (SCS [38] ) The SCS is a 10-item self-report questionnaire on which respondents indicate, on a 4-point Likert-type scale (1 = not at all like me; 4 = very much like me), the extent to which they experience sexual behavior as uncontrollable and distressing (e.g., BI have to struggle to control my sexual thoughts and behavior^). The SCS is reliable and valid among persons living with HIV [39] . Consistent with previous research [38] , the SCS had good internal consistency in the present sample (Cronbach's α = .87).
Beck Scale for Suicide Ideation (BSS [40] ) The BSS is a 21-item self-report measure that assesses suicidal thoughts, plans, and attempts in the past week as well as lifetime suicide attempts. The psychometric properties of the BSS are wellestablished [41] , and the internal consistency of the scale in the current study was found to be good (α = .87).
Procedures
Study procedures were conducted in accordance with the institutional review board. Informed consent was obtained from each participant at the beginning of the research appointment prior to administration of any study assessments. All participants were compensated with $20 in gift cards to a local grocery store. Data for the present investigation was collected between 2012 and 2015.
Analytic Strategy
Bivariate correlations among study variables were evaluated to examine associations between study variables. A series of hierarchical regression analyses were conducted with predictors centered at their respective means. Covariates included sex, self-identified ethnic group, time living with HIV, and negative affectivity; these were entered in the first step. Anxiety sensitivity and past-month smoking were entered together in the second step. Finally, the interaction of anxiety sensitivity and past-month smoking was entered in the final step. Post hoc simple slope analyses were performed for significant interaction terms at the two levels of the moderator variable (smoker versus non-smoker).
Results

Bivariate Relations
In the case of missing data, pair-wise deletion was used, resulting in 94 cases for suicidality and 77 cases for sexual compulsivity. There was an adequate amount of variance in scores for sexual compulsivity (mean = 15.07, SD = 6.72, range = 10-40) and suicidality (mean = 3.93, SD = 7.05, range = 0-28). Descriptive statistics and bivariate correlations are presented in Table 1 . Anxiety sensitivity was positively associated with sexual compulsivity (r = .38, p < .01) and suicidality (r = .42, p < .01). Smoking status was not associated with any of the criterion variables (rs from .03 to .21).
Moderation Analyses
In predicting sexual compulsivity (n = 77), covariates entered in the first step accounted for a non-significant amount of variance (R 2 = .12, F(4,73) = 2.42, p = .06), with gender being a significant predictor (β = .26, p = .031). There was a significant main effect for anxiety sensitivity (β = .43, p = .004), but not past-month smoking. As expected, there was also a significant interaction between anxiety sensitivity and past-month smoking (β = .63, t = 2.57, p = .013). Simple slope analyses revealed that anxiety sensitivity was positively associated with sexual compulsivity among individuals who reported past-month smoking (β = 4.52, p < .001), but not individuals who did not smoke in the past month (β = .67, p = .55; see Fig. 1) .
In order to test the unique moderating effect of smoking status on the relations between anxiety sensitivity and sexual compulsivity, an alternative model was conducted wherein sexual compulsivity was examined as a moderator between smoking status and anxiety sensitivity. In this instance, the interaction effect was non-significant (p > .05).
In regard to suicidal symptoms (n = 94), covariates entered in the first step accounted for a significant amount of variance (R 2 = .21, F(4,90) = 6.14, p < .001), with negative affectivity being a significant predictor (β = .45, p < .001). There were no significant main effects for anxiety sensitivity or pastmonth smoking. As hypothesized, there was a significant interaction between anxiety sensitivity and past-month smoking (β = .44, p = .030). Simple slope analyses revealed that anxiety sensitivity was positively associated with suicidality among individuals who had reported past-month smoking (β = 2.6, p = .01), but not individuals who did not smoke in the past month (β = −.13, p = .91; see Fig. 1 ).
In order to test the unique moderating effect of smoking status on the relations between anxiety sensitivity and suicidality, an alternative model was conducted wherein suicidality was examined as a moderator between smoking status and anxiety sensitivity. In this instance, the interaction effect was non-significant (p > .05). Negative affectivity = positive and negative affect schedule-negative affect subscale score [35] ; anxiety sensitivity = Anxiety Sensitivity Index-3 total scale score [36] ; past-month smoking = timeline follow-back self-report (0 = no, 1 = yes) [33] ; sexual compulsivity = Sexual Compulsivity Scale total scale score [38] ; suicidal symptoms = Beck Scale for Suicide Ideation total scale score [40] ; gender, race, years since HIV diagnosis, and negative affectivity were covariates *p < .05; **p < .01
Post Hoc Analyses
In order to more fully understand if smoking status, sexual compulsivity, and suicidality clustered more strongly around those with high (versus low) anxiety sensitivity, post hoc cluster analyses were conducted [42] . A twostep cluster analysis indicated two clusters in terms of anxiety sensitivity: those with low scores (n = 43 [40.6 %], mean = 9.02, SD = 6.12) and high scores (n = 63 [59.4 %], mean = 39.98, SD = 11.65). The cluster quality was good (silhouette measure of cohesion and separation >.05) for this two-cluster approach, and the ratio of cluster sizes was acceptable (1.47; [43] ).
Results indicated that the high-anxiety sensitivity (AS) cluster had significantly higher rates of sexual compulsivity compared to the low-AS cluster (16.06 and 12.60, respectively, F = 20.83, p < .05) and that the high-AS cluster had significantly higher rates of suicidality compared to the lower-AS cluster (5.78 and .86, respectively, F = 25.92, p < .001). However, the high-AS cluster and low-AS cluster did not significantly differ in terms of smoking status, as 52.4 % of the high-AS cluster and 60.5 % of the low-AS cluster were smokers (χ 2 = .68, p > .05). Because of our small sample size (77 and 94, respectively), post hoc power calculations were run for each model. Total model effect sizes, degrees of freedom for the hypothesis, and degrees of freedom for error were used to calculate power, as suggested by Cohen [44] . Power was calculated as .99 for both models.
Discussion
Previous investigations utilizing non-HIV+ samples have found that smoking status moderates the effect of anxiety sensitivity in regard to greater risk for negative emotional symptoms and psychopathology (e.g., anxiety, depression [9] ). The present study extended this literature by examining tobacco use as a novel, theory-based candidate moderator of the anxiety sensitivity-health problem relation among people with HIV/AIDS in terms of an array of common, clinically significant health problems, including hazardous drinking, sexual compulsivity, and suicidality.
In line with prediction, results indicated that smoking status significantly moderated the predictive influence of anxiety sensitivity in terms of suicidality and sexual compulsivity. Alternative models testing the moderating role of our outcome variables on the relations between smoking status and anxiety sensitivity were non-significant, providing evidence as to the unique moderating role of our a priori model. Anxiety sensitivity was significantly and robustly associated with each of the dependent variables among smokers, whereas the corresponding relations among non-smokers were non-significant. Each of these findings remained consistent when adjusting for Fig. 1 Plotting the interactive effects of anxiety sensitivity and past-month smoking for the dependent variables relevant covariates, including gender, self-identified ethnic group, years since HIV diagnosis, and negative affectivity. Importantly, the interactive effects of anxiety sensitivity and smoking status explained 7 % of the variance for sexual compulsivity and 4 % of the variance for suicidality (Table 2) . Although these effects are small, they are notable in that they are evident above and beyond a host of relevant covariates and the main effects of anxiety sensitivity and smoking status [4] . Thus, these represent potentially clinically meaningful results in terms of common health problems faced by persons with HIV/AIDS. These findings also are in accordance with transdiagnostic models of smoking comorbidity with mental health and physical health problems [4] . Previous investigations among non-HIV+ samples suggest that anxiety sensitivity is associated with greater tendencies to smoke to cope with adverse physical and mental health problems (e.g., [45] ) and that some of these relations mediate the association between this construct and health problems [46] . Thus, it is possible that people with HIV/AIDS who smoke may be especially vulnerable to the effects of anxiety sensitivity. Specifically, individuals with higher anxiety sensitivity who use tobacco as a coping method may be increasing their subjective distress, which, in turn, could place them at a greater risk for other maladaptive health behaviors (e.g., high-risk sexual behavior, deliberate, self-harm) to cope with such amplified distress. Post hoc cluster analyses also indicated that our sample consisted of two clusters in terms of anxiety sensitivity (low versus high) and that sexual compulsivity and suicidality, but not smoking status, were significantly higher among the highanxiety sensitivity group. These results further support our moderation analyses. Although the impetus for the present analyses was based on the theoretical position that tobacco use may increase the effect of anxiety sensitivity on health behavior problems among people with HIV/AIDS, the cross-sectional nature of the study allows for alternative explanations of the present findings. Previous evidence also suggests a prospective effect of smoking on other health behavior problems and disorders among people with HIV/AIDS (e.g., alcohol dependence [29] ). As we predicted, it may be that smoking can exacerbate the negative psychological effects of anxiety sensitivity among this group, thereby increasing the likelihood of additional maladaptive (coping) behaviors. Alternatively, smoking may be associated with shared factors that underlie the covariation of anxiety sensitivity and other health behaviors, such as neural abnormalities, genetic factors, and personality traits Negative affectivity = positive and negative affect schedule-negative affect subscale [35] ; anxiety sensitivity = Anxiety Sensitivity Index-3 [36] ; pastmonth smoking = timeline follow-back self-report (0 = no, 1 = yes) [33] ; sexual compulsivity = sexual compulsivity subscale [38] ; suicidal symptoms = Beck Scale for Suicide Ideation [40] *p < .05; **p < .01; ***p < .001 (e.g., impulsivity, negative urgency). In either case, it is interesting that the current analyses found little evidence indicating significant main effects of anxiety sensitivity or smoking status on the studied dependent variables. The sole exception being that anxiety sensitivity was significantly related to greater sexual compulsivity. These data highlight that the interplay of smoking and anxiety sensitivity is more impactful than their singular influence in terms of sexual compulsivity and suicidality. Such findings generally suggest that it is important to consider the health-related impact of these behavioral mechanisms (anxiety sensitivity and smoking) in terms of the complex and interacting systems in which they function. This study had several limitations. First, we are utilizing a cross-sectional correlational design and, as such, are unable to truly explore the potential moderating role of smoking in the examined relations. Second, self-report was used for all variables. This may be particularly impactful referring to smoking status, as there was no biochemical verification of tobacco use or measure of nicotine dependence. Third, the current study lacks data on underlying mechanisms (e.g., coping responses to negative mood states) and the absence of additional measures of other health behavior problems common among people with HIV/AIDS (e.g., medication adherence, high-risk sexual behavior). Despite the limitations, this study had several offsetting strengths, such as the use of multiple dependent variables, psychometrically sound instruments, and adjustment for numerous extraneous confounding and explanatory variables.
To our knowledge, this is the first study to examine whether smoking moderates the association between anxiety sensitivity and numerous health behavior problems among people with HIV/AIDS. The unique moderational relation demonstrated herein warrants future investigation as it points to putative etiological mechanisms that could account for the relation between anxiety sensitivity and adverse health outcomes among people with HIV/AIDS. Additionally, future work may explore other factors that may moderate the relations between anxiety sensitivity and health outcomes. Additional clarification of the temporal and causal nature of this moderational relation using longitudinal and experimental research designs would be informative. In addition, future investigations directly measuring additional maladaptive health behaviors, such as diet and physical inactivity, in addition to affective coping patterns as potential mechanisms explaining our findings would be useful for understanding the etiological processes linking anxiety sensitivity and negative health outcomes among this population. Consequently, more research is needed to more fully understand the inter-related nature of these mechanisms and prospective research is needed to truly understand moderation processes that underlie these observations. Such research could also have implications for matching interventions to patients with individual difference factors that predict unfavorable/favorable treatment response. For example, the present findings may suggest that interventions which target anxiety sensitivity and smoking in an integrative fashion may be useful in offsetting the risk for other health problems among people with HIV/AIDS, as has been found among non-HIV+ samples [47, 48] .
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